Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database
Diabetes, Obesity and Metabolism · 2024
DOI: 10.1111/dom.15611 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes, Obesity and Metabolism, 2024. Verfasst von Tomohiko Kanaoka und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan. Hauptthemen laut MEDLINE: Sodium-Glucose Transporter 2 Inhibitors, Glomerular Filtration Rate, Diabetes Mellitus, Type 2, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Ministry of Health, Labour and Welfare of Japan, Ministry of Health, Labour and Welfare.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Aim
Sodium‐glucose cotransporter 2 (SGLT2) inhibitors often cause a transient decrease in glomerular filtration rate (GFR) shortly after the initiation, referred to as the ‘initial drop’. However, the clinical significance of this initial drop in real‐world practice remains unclear. Materials and Methods Using the nationwide Japan Chronic Kidney Disease Database, we examined factors that affected the initial drop, in patients with chronic kidney disease (CKD) and type 2 diabetes mellitus (T2DM). We also evaluated the effects of the initial drop on a composite kidney outcome (a decline in GFR of ≥50% or progression to end‐stage kidney disease).
Results
Data from 2053 patients with CKD and T2DM newly prescribed an SGLT2 inhibitor were analysed. The follow‐up period after SGLT2 inhibitor administration was 1015 days (interquartile range: 532, 1678). Multivariate linear regression models revealed that the concomitant use of the renin‐angiotensin system inhibitors and diuretics, urinary protein levels ≥2+, and changes in GFR before the initiation of the SGLT2 inhibitor were associated with a larger initial GFR decline (β = −0.609, p = .039; β = −2.298, p < .001; β = −0.936, p = .048; β = −0.079, p < .001, respectively). Patients in the quartile with the largest initial GFR decline experienced a higher incidence of the subsequent composite kidney outcome than those in the other quartiles ( p < .001).
Conclusions
The concomitant use of renin‐angiotensin system inhibitors and diuretics, higher urine protein levels and pre‐treatment GFR changes were associated with a larger initial GFR decline. Of these factors, the use of a diuretic had the largest effect. Furthermore, patients with CKD and T2DM experiencing an excessive initial GFR drop might be at a higher risk of adverse kidney outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medical Science and Cardiorenal Medicine, Yokohama City University Graduate School of Medicine, Yokohama, Japan.
- Non-communicable Disease Epidemiology Research Centre, Shiga University of Medical Science, Otsu, Japan.
- Department of Nephrology and Hypertension, Kawasaki Medical School, Kurashiki, Japan.
- Genki Plaza Medical Centre for Health Care, Tokyo, Japan.
- Division of Nephrology and Endocrinology, University of Tokyo Graduate School of Medicine, Tokyo, Japan.
- Division of Cardiology, Nephrology, Pulmonology and Neurology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
ORCID-Profile: Hiromichi Wakui
Förderung
- Japan Agency for Medical Research and Development
- Ministry of Health, Labour and Welfare of Japan
- Ministry of Health, Labour and Welfare
Zitieren
APA
Kanaoka, T., Wakui, H., Yano, Y., Nagasu, H., Kanegae, H., Nangaku, M., Hirakawa, Y., Nakagawa, N., Wada, J., Tsuruya, K., Nakano, T., Maruyama, S., Wada, T., Konishi, M., Nagahiro, T., Yamagata, K., Narita, I., Yanagita, M., Terada, Y., …, & J‐CKD‐DB investigators (2024). Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.15611
Vancouver
Kanaoka T, Wakui H, Yano Y, Nagasu H, Kanegae H, Nangaku M, et al. Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database. Diabetes, Obesity and Metabolism. 2024. doi:10.1111/dom.15611
BibTeX
@article{Kanaoka2024,
author = {Kanaoka, Tomohiko and Wakui, Hiromichi and Yano, Yuichiro and Nagasu, Hajime and Kanegae, Hiroshi and Nangaku, Masaomi and Hirakawa, Yosuke and Nakagawa, Naoki and Wada, Jun and Tsuruya, Kazuhiko and Nakano, Toshiaki and Maruyama, Shoichi and Wada, Takashi and Konishi, Masaaki and Nagahiro, Takanori and Yamagata, Kunihiro and Narita, Ichiei and Yanagita, Motoko and Terada, Yoshio and Araki, Shinichi and Emoto, Masanori and Okada, Hirokazu and Isaka, Yoshitaka and Suzuki, Yusuke and Yokoo, Takashi and Kataoka, Hiromi and Kanda, Eiichiro and Kashihara, Naoki and Tamura, Kouichi and J‐CKD‐DB investigators, J‐CKD‐DB investigators},
title = {Factors affecting the sodium‐glucose cotransporter 2 inhibitors‐related initial decline in glomerular filtration rate and its possible effect on kidney outcome in chronic kidney disease with type 2 diabetes: The Japan Chronic Kidney Disease Database},
journal = {Diabetes, Obesity and Metabolism},
year = {2024},
doi = {10.1111/dom.15611}
}
EUVIMED